Publication|Articles|September 24, 2025
Supplements and Featured Publications
- Long-Acting Injectable Administration In Schizophrenia With Insights From Genoa Healthcare® Pharmacy
Long-Acting Injectable Program Implementation Insights From Genoa Healthcare® Pharmacy
Listen
0:00 / 0:00
Advertisement
This educational resource was sponsored by Johnson & Johnson.
Part 2 of this educational resource provides insights for institutions seeking to implement a pharmacist-led long-acting injectable administration program for schizophrenia.
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Blinatumomab Boosts Survival in Pediatric ALL, but Faces Delivery Hurdles
2
Digital Innovation and New Drugs Converge to Transform CRM Care
3
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
4
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
5





































